Ruxolitinib Interactions
There are 510 drugs known to interact with ruxolitinib, along with 12 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 137 are major, 312 are moderate, and 61 are minor.
- View all 510 medications that may interact with ruxolitinib
- View ruxolitinib alcohol/food interactions (2)
- View ruxolitinib disease interactions (12)
Most frequently checked interactions
View interaction reports for ruxolitinib and the medicines listed below.
- Ambien (zolpidem)
- Amrix (cyclobenzaprine)
- Ativan (lorazepam)
- Celexa (citalopram)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Concerta (methylphenidate)
- CoQ10 (ubiquinone)
- Cosopt (dorzolamide / timolol ophthalmic)
- Coumadin (warfarin)
- Eliquis (apixaban)
- Entresto (sacubitril / valsartan)
- Focalin (dexmethylphenidate)
- Heparin Sodium (heparin)
- Humira (adalimumab)
- Iron Sulfate (ferrous sulfate)
- Lumigan (bimatoprost ophthalmic)
- Metoprolol Tartrate (metoprolol)
- Oramorph SR (morphine)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Singulair (montelukast)
- Sotalol Hydrochloride AF (sotalol)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Ruxolitinib alcohol/food interactions
There are 2 alcohol/food interactions with ruxolitinib.
Ruxolitinib disease interactions
There are 12 disease interactions with ruxolitinib which include:
- cardiovascular risk
- malignancy
- thrombosis
- lung toxicity
- cytopenia
- hepatic impairment
- Hepatitis B
- infections
- lipid elevations
- PML
- renal impairment
- tuberculosis
Report options
More about ruxolitinib
- ruxolitinib consumer information
- Compare alternatives
- Reviews (43)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Ibrutinib
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase inhibitor used for certain blood cancers and ...
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Rayos
Rayos (prednisone, delayed-release) is used to treat rheumatoid arthritis, polymyalgia rheumatica ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
